Hazards of dynamic testing of pituitary function

Clinical Endocrinology

Volumn 58, Issue 5, 2003, Pages 543-544

  Levy, Andy ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; HYDROCORTISONE; HYPOTHALAMUS HORMONE;

ANAMNESIS; CLINICAL FEATURE; CORTICOTROPIN BLOOD LEVEL; CORTICOTROPIN TEST; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; DOSE RESPONSE; DYSPHORIA; ENDOCRINE FUNCTION TEST; FLUSHING; HAZARD ASSESSMENT; HORMONAL REGULATION; HORMONAL THERAPY; HORMONE DETERMINATION; HORMONE RESPONSE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPERCORTISOLISM; HYPOPHYSIS APOPLEXY; HYPOPHYSIS FUNCTION; LABORATORY TEST; NAUSEA; NONHUMAN; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK ASSESSMENT;

ANIMALS; CORTICOTROPIN-RELEASING HORMONE; CUSHING SYNDROME; HUMANS; PITUITARY APOPLEXY; PITUITARY FUNCTION TESTS; PITUITARY GLAND, ANTERIOR; RATS;

EID: 0037994325     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.2003.01747.x     Document Type: Note

References (15)

1. Biousse, V., Newman, N.J. & Oyesiku, N.M. (2001) Precipitating factors in pituitary apoplexy. Journal of Neurology, Neurosurgery and Psychiatry, 71, 542-545.
2. Carlsson, P.O., Stridsberg, M. & Jansson, L. (1995) Influence of corticotropin-releasing factor on pancreatic and islet blood flow in different regions of the rat pancreas. Digestion, 56, 242-245.
3. Clifton, V.L., Read, M.A., Leitch, I.M., Giles, W.B., Boura, A.L., Robinson, P.J. & Smith, R. (1995) Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: involvement of the nitric oxide-cyclic guanosine 3′,5′-monophosphate-mediated pathway. Journal of Clinical Endocrinology and Metabolism, 80, 2888-2893.
4. Grosskreutz, C.L. & Brody, M.J. (1988) Regional hemodynamic responses to central administration of corticotropin-releasing factor (CRF). Brain Research, 442, 363-367.
5. Kaplan, B., Day, A.L., Quisling, R. & Ballinger, W. (1983) Hemorrhage into pituitary adenomas. Surgical Neurology, 20, 280-287.
6. Kubler, A., Rothacher, G., Knappertz, V.A., Kramer, G., Nink, M., Beyer, J. & Lehnert, H. (1994) Intra- and extracerebral blood flow changes and flushing after intravenous injection of human corticotropin-releasing hormone. Clinical Investigation, 72, 331-336.
7. Liu, Y., Yuan, X. & Liu, J. (1998) A primary study of microanatomy on blood supplement of large and huge pituitary adenoma. Bulletin of Hunan Medical University, 23, 552-554.
8. Masago, A., Ueda, Y., Kanai, H., Nagai, H. & Umemura, S. (1995) Pituitary apoplexy after pituitary function test: a report of two cases and review of the literature.' Surgical Neurology, 43, 158-164.
9. Masson, E.A., Atkin, S.L., Diver, M. & White, M.C. (1993) Pituitary apoplexy and sudden blindness following the administration of gonadotrophin releasing hormone. Clinical Endocrinology, 38, 109-110.
10. Matsuura, I., Saeki, N., Kubota, M., Murai, H. & Yamaura, A. (2001) Infarction followed by hemorrhage in pituitary adenoma due to endocrine stimulation test. Endocrine Journal, 48, 493-498.
11. Overton, J.M. & Fisher, L.A. (1991) Differentiated hemodynamic responses to central versus peripheral administration of corticotropin-releasing factor in conscious rats. Journal of the Autonomic Nervous System, 35, 43-51.
12. Reznik, Y., Chapon, F., Lahlou, N., Deboucher, N. & Mahoudeau, J. (1997) Pituitary apoplexy of a gonadotroph adenoma following gonadotrophin-releasing hormone agonist therapy for prostatic cancer. Journal of Endocrinological Investigation, 20, 566-568.
13. Vidal, S., Kovacs, K., Horvath, E., Scheithauer, B.W., Kuroki, T. & Lloyd, R.V. (2001) Microvessel density in pituitary adenomas and carcinomas. Virchows Archive, 438, 595-602.
14. Wei, E.T. & Gao, G.C. (1991) Corticotropin-releasing factor: an inhibitor of vascular leakage in rat skeletal muscle and brain cortex after injury. Regulatory Peptides, 33, 93-104.
15. Yanovski, J.A., Cutler, G.B.J., Chrousos, G.P. & Nieman, L.K. (1998) The dexamethasone-suppressed corticotropin-releasing hormone stimulation test differentiates mild Cushing's disease from normal physiology. Journal of Clinical Endocrinology and Metabolism, 83, 348-352.